New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S3789

Introduced
5/8/23  

Caption

Requires hospital urine drug screenings to include test for fentanyl.

Impact

The passage of S3789 will modify current hospital protocols concerning drug testing during the diagnostic process. Traditionally, urine tests included analyses for various illicit substances, but fentanyl was omitted despite its growing prevalence in overdose-related incidents. Implementing this bill could lead to enhanced safety measures within hospitals, aiding medical professionals in quickly identifying and treating fentanyl-related emergencies, which could ultimately save lives. Furthermore, the bill sets a sunset clause, with the law expiring on January 1, 2028, suggesting a need for future review and assessment of its effectiveness.

Summary

Senate Bill S3789, introduced in the New Jersey Legislature, mandates that urine drug screenings conducted in general acute care hospitals must include a test for fentanyl. Fentanyl, a potent synthetic opioid, has become a significant contributor to the overdose crisis, often found as an adulterant in other recreational drugs like heroin and cocaine. By adding fentanyl testing to standard drug panels, the bill aims to ensure that patients who may have ingested fentanyl, whether knowingly or unknowingly, receive appropriate medical attention for possible overdoses. This requirement is seen as a proactive measure to tackle the rising number of overdose deaths linked to fentanyl use.

Contention

While the bill is aimed at addressing a critical public health issue, some stakeholders may raise concerns about the feasibility and implementation of the additional testing requirement. Hospitals may face increased costs due to the need for new testing protocols and potential changes in equipment or training staff. Additionally, there may be discussions around the privacy of patients undergoing drug screenings and the implications of mandatory testing on those seeking medical care. Nevertheless, the bill's advocates stress that the urgency of preventing overdose deaths necessitates such measures.

Companion Bills

NJ A5489

Same As Requires hospital urine drug screenings to include test for fentanyl.

Previously Filed As

NJ S696

Requires hospital urine drug screenings to include test for fentanyl.

NJ A3094

Requires hospital urine drug screenings to include test for fentanyl.

NJ A5489

Requires hospital urine drug screenings to include test for fentanyl.

NJ S3274

Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

NJ A4057

Requires hospitals to test for fentanyl and xylazine as part of urine drug screenings.

NJ HB2742

Hospitals; urine drug screening to include testing for fentanyl.

NJ SB864

General acute care hospitals: drug screening.

NJ HB5113

Health facilities: hospitals; certain drug screen conducted in hospitals; require to include a test for fentanyl and to provide certain reporting. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 21525.

NJ SB1209

Hospitals; fentanyl testing

NJ S4430

Requires hospitals to notify family of patient release following drug overdose.

Similar Bills

CA AB1673

California Fentanyl Abuse Task Force.

CA SB19

Fentanyl Misuse and Overdose Prevention Task Force.

CA AB2429

Pupil instruction: health education courses: fentanyl.

CA AB33

Fentanyl Misuse and Overdose Prevention Task Force.

CA AB3224

California Fentanyl Abuse Task Force.

CA AB2341

Criminal procedure: sentencing credits.